Skip to main content

Table 1 Epidemiological characteristics

From: CpG signalling, H2A.Z/H3 acetylation and microRNA-mediated deferred self-attenuation orchestrate foetal NOS3 expression

 

Total ( n = 39)

Flow group 0 ( n = 10)

Flow group 1 ( n = 12)

Flow group 2 ( n = 10)

Flow group 3 ( n = 7)

Gestational age (SD)

31.9 ± 4.9

31.8 ± 4.8

31.6 ± 5.7

32.1 ± 4.9

31.2 ± 4.6

Birth weight in g (SD)

1,655 ± 917

1,746 ± 1,008

1,652 ± 810

1,636 ± 909

1,336 ± 657

Birth length in cm (SD)

41.4 ± 6.1

41.0 ± 7.1

40.7 ± 6.1

41.9 ± 5.5

40.7 ± 5.2

Maternal age (SD)

31.9 ± 4.9

31.8 ± 4.8

31.6 ± 5.7

31.2 ± 4.9

31.2 ± 4.6

Ponderal index

21.9 ± 3.5

23.3 ± 2.8

22.9 ± 3.5

19.7 ± 3.0

18.8 ± 1.98

Apgar at 5 min

8.5 ± 1.2

8.5 ± 1.4

8.7 ± 1.3

8.4 ± 1.3

8.3 ± 1.1

pH at birth

7.34 ± 1.1

7.34 ± 1.2

7.33 ± 1.1

7.35 ± 1.4

7.32 ± 1.2

Female (%)

54

42

58

60

57

HELLP syndrome (%)

7.7

-

-

10

28.6

Preeclampsia (%)

15.4

-

8.3

20

42.9